Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1997 May;76(5):445–448. doi: 10.1136/adc.76.5.445

Continuous midazolam infusion as treatment of status epilepticus

R L Koul 1, G R Aithala 1, A Chacko 1, R Joshi 1, M S Elbualy 1
PMCID: PMC1717195  PMID: 9196363

Abstract

Accepted 5 February 1997


In a tertiary referral centre, midazolam infusion was tried as treatment for 20 children with status epilepticus over a period of two years. The mean age of the children was 4.07 years. Twelve children with refractory status epilepticus had received intravenous or per rectal diazepam and intravenous phenytoin/phenobarbitone or both before midazolam was given (0.15 mg/kg bolus followed by 1-5 µg/kg/min infusion). Eight children required only midazolam to control the established status epilepticus. The seizures were controlled in 19 children. The mean time required for complete cessation of seizures was 0.9 hours. The mean infusion rate required was 2.0 µg/kg/min. All children had regained full consciousness by a mean of 5.1 hours after discontinuation of midazolam treatment. No metabolic derangement or compromise of vital functions was noted in any of the children. Midazolam infusion is thus an effective and safe therapeutic approach for the management of childhood status epilepticus.



Full Text

The Full Text of this article is available as a PDF (69.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amrein R., Hetzel W. Pharmacology of Dormicum (midazolam) and Anexate (flumazenil). Acta Anaesthesiol Scand Suppl. 1990;92:6–47. [PubMed] [Google Scholar]
  2. Bleck T. P. Advances in the management of refractory status epilepticus. Crit Care Med. 1993 Jul;21(7):955–957. doi: 10.1097/00003246-199307000-00004. [DOI] [PubMed] [Google Scholar]
  3. Browne T. R. Paraldehyde, chlormethiazole, and lidocaine for treatment of status epilepticus. Adv Neurol. 1983;34:509–517. [PubMed] [Google Scholar]
  4. Celesia G. G. Modern concepts of status epilepticus. JAMA. 1976 Apr 12;235(15):1571–1574. [PubMed] [Google Scholar]
  5. Crisp C. B., Gannon R., Knauft F. Continuous infusion of midazolam hydrochloride to control status epilepticus. Clin Pharm. 1988 Apr;7(4):322–324. [PubMed] [Google Scholar]
  6. Domino E. F. Comparative seizure inducing properties of various cholinesterase inhibitors: antagonism by diazepam and midazolam. Neurotoxicology. 1987 Spring;8(1):113–122. [PubMed] [Google Scholar]
  7. Dundee J. W., Halliday N. J., Harper K. W., Brogden R. N. Midazolam. A review of its pharmacological properties and therapeutic use. Drugs. 1984 Dec;28(6):519–543. doi: 10.2165/00003495-198428060-00002. [DOI] [PubMed] [Google Scholar]
  8. Galvin G. M., Jelinek G. A. Midazolam: an effective intravenous agent for seizure control. Arch Emerg Med. 1987 Sep;4(3):169–172. doi: 10.1136/emj.4.3.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ghilain S., van Rijckevorsel-Harmant K., Harmant J., de Barsy T. H. Midazolam in the treatment of epileptic seizures. J Neurol Neurosurg Psychiatry. 1988 May;51(5):732–732. doi: 10.1136/jnnp.51.5.732-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hauser W. A. Status epilepticus: frequency, etiology, and neurological sequelae. Adv Neurol. 1983;34:3–14. [PubMed] [Google Scholar]
  11. Kofke W. A., Snider M. T., Young R. S., Ramer J. C. Prolonged low flow isoflurane anesthesia for status epilepticus. Anesthesiology. 1985 May;62(5):653–656. doi: 10.1097/00000542-198505000-00023. [DOI] [PubMed] [Google Scholar]
  12. Kumar A., Bleck T. P. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med. 1992 Apr;20(4):483–488. doi: 10.1097/00003246-199204000-00009. [DOI] [PubMed] [Google Scholar]
  13. Raines A., Henderson T. R., Swinyard E. A., Dretchen K. L. Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus. Epilepsia. 1990 May-Jun;31(3):313–317. doi: 10.1111/j.1528-1157.1990.tb05381.x. [DOI] [PubMed] [Google Scholar]
  14. Reves J. G., Fragen R. J., Vinik H. R., Greenblatt D. J. Midazolam: pharmacology and uses. Anesthesiology. 1985 Mar;62(3):310–324. [PubMed] [Google Scholar]
  15. Rivera R., Segnini M., Baltodano A., Pérez V. Midazolam in the treatment of status epilepticus in children. Crit Care Med. 1993 Jul;21(7):991–994. doi: 10.1097/00003246-199307000-00011. [DOI] [PubMed] [Google Scholar]
  16. Shorvon S. Tonic clonic status epilepticus. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):125–134. doi: 10.1136/jnnp.56.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stores G., Zaiwalla Z., Styles E., Hoshika A. Non-convulsive status epilepticus. Arch Dis Child. 1995 Aug;73(2):106–111. doi: 10.1136/adc.73.2.106. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES